Byrne Asset Management LLC Elanco Animal Health Inc Transaction History

Byrne Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$8.08 - $10.37 $969 - $1,244	120 Added 17.14%	820 $8,000
Q1 2023 Apr 17, 2023	BUY	$8.79 - $14.58 $527 - $874	60 Added 9.38%	700 $6,000
Q4 2022 Jan 30, 2023	BUY	$11.49 - $13.65 $344 - $409	30 Added 4.92%	640 $7,000
Q3 2022 Oct 19, 2022	BUY	$12.41 - $32.42 $744 - $1,945	60 Added 10.91%	610 $8,000
Q2 2022 Jul 20, 2022	BUY	$19.63 - $26.62 $785 - $1,064	40 Added 7.84%	550 $11,000
Q1 2022 Apr 05, 2022	BUY	$24.65 - $29.0 $2,711 - $3,190	110 Added 27.5%	510 $13,000
Q4 2021 Feb 22, 2022	BUY	$27.74 - $34.09 $11,096 - $13,636	400 New	400 $11,000

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Byrne Asset Management LLC with notifications on news.